Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
| Open-market buy | 06/01 | 06/02 | 273,500 sh2 trades | $74.29avg. | $20,318,415 | No record | ||
| Open-market sale | 23/05/30–23/10/25 | 03/25 | 30 sh2 trades | $71.77avg. | $2,153.1 | −6.1% | ||
| Open-market buy | 23/03/24–23/08/04 | 03/25 | 25 sh2 trades | $82.28avg. | $2,056.95 | +5.5% | ||
| Open-market buy | 03/12–03/13 | 03/16 | 14,260 sh2 trades | $69.79avg. | $995,179 | +18.4% | ||
| Open-market buy | 25/08/27–03/12 | 03/16 | 156,459 sh6 trades | $70.13avg. | $10,971,804.34 | No record | ||
| Open-market sale | 25/09/29–25/12/15 | 03/16 | 222 sh4 trades | $65.23avg. | $14,481.43 | −96.5% | ||
Stephen N. LandsmanEVP, General Counsel | Open-market buy | 25/12/12 | 25/12/12 | 3,100 sh | $63.48 | $196,788 | +25.8% | |
Fribourg Paul J.Director | Open-market buy | 25/08/07 | 25/08/08 | 15,450 sh | $64.80 | $1,001,160 | No record | |
| Open-market buy | 25/08/07 | 25/08/07 | 15,300 sh | $64.95 | $993,735 | +24.6% | ||
Kevin O'ByrneDirector | Open-market buy | 25/05/22 | 25/05/23 | 4,500 sh | $76.05 | $342,225 | +140.8% | |
Hernandez Margarita PalauDirector | Open-market buy | 25/05/19 | 25/05/20 | 850 sh | $77.42 | $65,807 | +55.1% | |
| Open-market buy | 25/05/19 | 25/05/19 | 12,000 sh2 trades | $77.28avg. | $927,360 | No record | ||
Beril YildizCAO, SVP & Controller | Open-market sale | 25/05/19 | 25/05/19 | 2,400 sh | $77.34 | $185,616 | −41.9% | |
| Open-market buy | 25/05/15 | 25/05/15 | 4,000 sh2 trades | $75.33avg. | $301,317 | +662.3% | ||
| Open-market buy | 25/05/08–25/05/09 | 25/05/09 | 25,000 sh2 trades | $73.97avg. | $1,849,271 | +67.4% | ||
Kevin O'ByrneDirector | Open-market buy | 25/03/05 | 25/03/06 | 6,500 sh | $80.44 | $522,860 | No record | |
| Open-market buy | 25/03/04 | 25/03/05 | 25,000 sh | $80.24 | $2,006,000 | +581.4% | ||
Yuvraj AroraPresident, Nourish | Open-market sale | 24/11/11 | 24/11/12 | 5,000 sh | $91.76 | $458,800 | −60.7% | |
Angela StrzeleckiPresident, Pharma Solutions | Open-market sale | 24/06/13 | 24/06/14 | 2,588 sh | $95.66 | $247,568.08 | −23.3% | |
de Villeplee Christophe FauchonPresident, Scent | Open-market sale | 23/05/11 | 23/05/12 | 1,972 sh | $86.35 | $170,282.2 | −17.8% |